Mater Private Network announces €5.6 million investment in innovative cancer care technology 7 months ago
Astellas’ Veoza™ (fezolinetant) now available in Ireland for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause 2 years ago